Shenzhen Hepalink Pharmaceutical Group is a leading multinational biopharmaceutical company that specialises in the production of heparin and its derivatives. Founded in 1986, the company has more than 31 years of experience in heparin research and production. It is recognised as one of the largest suppliers of heparin sodium API in the world, equipped with advanced technology and committed to ensuring the safest quality products. Hepalink has established itself as a trusted supplier for internationally renowned pharmaceutical companies and is dual listed in Hong Kong and mainland China. The company focuses on developing its industry chain from crude heparin to finished preparations, leveraging its expertise in heparin sodium API to enhance its offerings.

Services include:
- Contract Development and Manufacturing (CDMO)
- Heparin sodium API supply
- Biologics CDMO services
- Research and development
- Commercialisation services

Shenzhen Hepalink Pharmaceutical Group is dedicated to advancing the biopharmaceutical industry through its comprehensive services and high-quality products. For more information, please visit hepalink.com.